medicare reclast requirements

Does anyone know if medicare requires intollerance of oral medications along with a t score of -2.5 or greater for coverage or is that only for Capital Blue Cross?

Reclast

The World Health Organization (WHO) defines osteoporosis as spine, hip, or
wrist bone mineral density (BMD) T-score <-2.5 or prevalent fragility fracture;
and severe osteoporosis as T-score <-2.5 and prevalent fragility fracture. Reclast Injection is indicated for the treatment of:
1. Paget's disease of bone in men and women effective with FDA approval April 16, 2007. Treatment is indicated in patients with Paget’s disease of bone with elevations in serum alkaline phosphatase of two times or higher than the upper limit of the age-specific normal reference range, or those who are symptomatic, or those at risk for complications from their disease, to induce remission (normalization of serum alkaline phosphatase). 2. Postmenopausal osteoporosis--The recommended dose of Reclast® for treatment of postmenopausal osteoporosis is a single 5 mg infusion once a year given intravenously over no less than 15 minutes. (5 mg in a 100 mL ready to infuse solution). Most payors will follow the WHO definitions.